Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Swedish Orphan Biovit Ord (BIOVF)

Swedish Orphan Biovit Ord (BIOVF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 6,576,268
  • Shares Outstanding, K 299,978
  • Annual Sales, $ 1,663 M
  • Annual Income, $ 353,710 K
  • 60-Month Beta 0.48
  • Price/Sales 5.25
  • Price/Cash Flow 12.31
  • Price/Book 2.61
Trade BIOVF with:
  • Price/Earnings ttm 22.27
  • Earnings Per Share ttm 0.57
  • Most Recent Earnings 0.18 on 10/22/21
  • Next Earnings Date 07/20/22
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/22
See More
  • Average Estimate 0.08
  • Number of Estimates 1
  • High Estimate 0.08
  • Low Estimate 0.08
  • Prior Year 0.11
  • Growth Rate Est. (year over year) -27.27%

Price Performance

See More
Period Period Low Period High Performance
1-Month
20.3600 +7.67%
on 06/13/22
22.3900 -2.09%
on 06/03/22
+0.2225 (+1.03%)
since 05/26/22
3-Month
19.8400 +10.50%
on 05/10/22
24.5000 -10.52%
on 04/07/22
-0.8275 (-3.64%)
since 03/25/22
52-Week
17.7000 +23.86%
on 07/16/21
28.8800 -24.09%
on 09/07/21
+3.7425 (+20.59%)
since 06/30/21

Most Recent Stories

More News
Swedish Orphan Biovitrum (BIOVF) Stock Jumps 5.3%: Will It Continue to Soar?

Swedish Orphan Biovitrum (BIOVF) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength...

BIOVF : 21.9225 (-1.56%)
CHRS : 8.33 (+6.39%)
Spero Therapeutics, Inc. (SPRO) Reports Q1 Loss, Lags Revenue Estimates

Spero Therapeutics, Inc. (SPRO) delivered earnings and revenue surprises of -16.09% and 27.40%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?...

SPRO : 0.7861 (-4.99%)
BIOVF : 21.9225 (-1.56%)
ChromaDex (CDXC) Reports Q1 Loss, Misses Revenue Estimates

ChromaDex (CDXC) delivered earnings and revenue surprises of -22.22% and 0.90%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

CDXC : 1.7300 (+3.59%)
BIOVF : 21.9225 (-1.56%)
Rapt Therapeutics (RAPT) Reports Q1 Loss, Tops Revenue Estimates

Rapt Therapeutics (RAPT) delivered earnings and revenue surprises of -4.55% and 60.25%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

RAPT : 18.93 (+4.76%)
BIOVF : 21.9225 (-1.56%)
Earnings Preview: Swedish Orphan Biovitrum (BIOVF) Q3 Earnings Expected to Decline

Swedish Orphan Biovitrum (BIOVF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

BIOVF : 21.9225 (-1.56%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakening short term outlook on maintaining the current direction.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Key Turning Points

3rd Resistance Point 21.9225
2nd Resistance Point 21.9225
1st Resistance Point 21.9225
Last Price 21.9225
1st Support Level 21.9225
2nd Support Level 21.9225
3rd Support Level 21.9225

See More

52-Week High 28.8800
Fibonacci 61.8% 24.6092
Fibonacci 50% 23.2900
Fibonacci 38.2% 21.9708
Last Price 21.9225
52-Week Low 17.7000

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar